AP
Insider
Andrew Stewart Plump
President, R&DAndrew Stewart Plump (President, R&D) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Takeda Pharmaceutical Company Limited (TAK). The largest single filing was $2.8M of TAK (165,393 sh × $17.10, as filed), executed Aug 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.3M
shares × price, as filed
Last traded
Sep 2
Filed Sep 3
Median ADV $57.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TAKRecent filings
TAKSALE
Takeda Pharmaceutical Company Limited
View filing →
$2.1M116,191 sh × $18.49
Exec Sep 2
Filed Sep 3 · 9:49 PM ET TAKSALE Takeda Pharmaceutical Company Limited View filing → $363K
19,651 sh × $18.49
Exec Aug 19
Filed Aug 21 · 4:30 PM ET TAKSALE Takeda Pharmaceutical Company Limited View filing → $2.8M
165,393 sh × $17.10
Exec Aug 10
Filed Aug 12 · 9:50 PM ET